Skip to main content

Table 1 Background characteristics of the study companies in the 2004 and 2008 surveys.

From: The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland

 

Survey 2004

n of respondents (%)

Survey 2008

n of respondents (%)

P-value

Number of companies

  

1.000

All

23

22

 

Original products

16 (70)

16 (73)

 

Generic products

7 (30)

6 (27)

 

Number of employees

   

Original product companies

  

0.732

≤19

1 (7)

4 (25)

 

20-49

1 (7)

2 (13)

 

50-99

7 (50)

5 (31)

 

100-149

2 (14)

2 (13)

 

≥150

3 (22)

3 (19)

 

Generic product companies

  

0.470

≤19

5 (71)

2 (40)

 

20-49

-

-

 

50-99

2 (29)

1 (20)

 

100-149

-

1 (20)

 

≥150

-

1 (20)

 

Turnover of the companies (€) a

   

Original product companies

  

0.381

≤1,000,000

-

-

 

1,000,001-20,000,000

1 (7)

6 (37)

 

20,000,001-40,000,000

5 (36)

2 (13)

 

40,000,001-60,000,000

3 (22)

3 (19)

 

60,000,001-80,000,000

2 (14)

1 (6)

 

80,000,001-100,000,000

1 (7)

2 (13)

 

≥100,000,001

2 (14)

2 (13)

 

Generic product companies

  

0.755

≤1,000,000

1 (14)

1 (17)

 

1,000,001-20,000,000

5 (72)

3 (50)

 

20,000,001-40,000,000

1 (14)

-

 

40,000,001-60,000,000

-

1 (17)

 

60,000,001-80,000,000

-

-

 

80,000,001-100,000,000

-

-

 

≥100,000,001

-

1 (17)

 

Median proportion (%) of turnover coming from the sale of pharmaceutical products included on the list of interchangeable medicines b

 

All

25 (range 1.5-100)

11 (range 1-93)

0.749

Original product companies

23 (range 1.5-80)

8.5 (range 1-70)

0.527

Generic product companies

30 (range 5-100)

45 (range 5.4-93)

0.836

Median proportion (%) of turnover coming from the sale of pharmaceutical products included in the price corridor b

 

All

10 (range 0-90)

8.2 (range 0-90)

0.767

Original product companies

7.5 (range 0-50)

3.5 (range 0-70)

0.608

Generic product companies

30 (range 5-90)

45 (range 5.4-90)

0.836

Median market share (%) in the Finnish pharmaceutical market b

 

All

1.9 (range 0.1-10)

1.9 (range 0.1-9)

0.904

Original product companies

3.8 (range 0.6-10)

2.0 (range 0.3-8)

0.354

Generic product companies

0.3 (range 0.1-2)

0.3 (range 0.1-9)

0.662

  1. aThe companies reported their turnover from 2003 in the 2004 survey and from 2006 in the 2008 survey.
  2. bThe companies reported their proportion (%) from 2006 in the 2008 survey.